Background: Langerhans cell histiocytosis is a relatively rare unique disease process characterized by an abnormal
Background
called as histiocytosis X [1] . Langerhans cell histiocytosis (LCH) also known as histiocytosis X, a rare disease characterized by monoclonal proliferation of dendritic-cell related histiocytes (Langerhans cells).
These histiocytes have destructive behaviour for the surrounding tissue, which they infiltrate. Among the organs often involved are the skeletal system, skin, thyroid gland and risk organs like liver, lung, and spleen.
Lichtenstein gave the term histiocytosis X in 1953 to include three clinical varieties including Eosinophilic Granuloma, Hand-Schüller-Christian, and Letterer-Siwe disease, which shared some common histologic features and clinical findings [2] . In 1973, the term Langerhans cell histiocytosis was introduced as an alternative to histiocytosis X [3] . The etiology of the disease is unknown, although there are some evidences that the disorder is a manifestation of an immunological aberration [4] . It is a rare pathology with an incidence of 1 in 560,000, more frequent affecting males than females, with a reported ratio ranging from 1.1:1 to 4:1 [5] . 75% of the cases occurs in children and young adults under 25 years [6, 7] .
The disease may involve multiple tissues or remain localized to a single organ, especially lung and bone.
Incidence in the jaws is 7.9%, in mandible, the body and angle are the most commonly affected sites [5] .Oral lesions may be the earliest and only manifestations of the disease in majority of the cases [8, 9] . Pain and bony swelling are the most commonly presenting complaints.
Intraoral finding includes gingival necrosis, mucosal ulceration, loosening and premature exfoliation of the teeth, precocious eruption of permanent dentition, ectopic eruption of permanent molars and halitosis [8, 10, 11] .
Langerhans cell histiocytosis presents a diagnostic challenge because it may manifest with a heterogeneous 
Discussion
The aim of this paper is to present an overview on current diagnostic and treatment strategies of LCH in the oral and maxillofacial region. Histiocytoses are rare diseases of great biological variability and a wide range of clinical manifestations. According to the working group of the Histiocyte Society, they are presently divided into dendritic cell disorders, macrophage-related disorders, and malignant histiocytic disorders [12] .Current classification of the histiocytic disorders ( The first manifestations of LCH may occur in the oral cavity [13] . Symptoms that would cause a patient to consult a dentist vary from a continuous gingival infection or a dental abscess to necrotizing ulcerating defects or a painful jaw swelling. Loosening and early exfoliation of (deciduous) teeth should alert the dentist.
Sometimes the lesions are asymptomatic. In a series of 50 patients with LCH, 36 per cent had oral involvement and the dentist was the first to see them in 16 per cent of the cases [14] . Radiographic features of LCH may be apparent about 6 weeks after the onset of the first symptoms [15] . The radiographic features are non-specific and may resemble, amongst others, odontogenic cysts, periapical lesions, periodontal disease, osteomyelitis or even malignant neoplasms. Involvement of the skull and other flat bones in LCH appear as punched-out, osteolytic lesions. In the maxilla an mandible, the disease may appear as periapical lesions [15] . or as advanced periodontal disease with severe loss of alveolar bone [16] .
In general, LCH in bone , manifests itself as a well-demarcated, round or oval cystic radiolucency with no peripheral bone condensation [15] . et al., 1999) . In these cases, the treatment is solely surgical. In stage III or when the internal organs are afflicted, combined treatment by chemotherapy, radiotherapy and corticoids is necessary [1] .
Conventional treatment of LCH is with surgery, radiotherapy, chemotherapy and steroid injections, alone or in combination as indicated by the extent of the disease [18] . The treatment of jaw lesions consists mainly of curettage. A recurrence rate of 16 per cent has been reported [19] and recurrences have been observed up to 11 years after first treatment [20] .Radiotherapy and/or chemotherapy should be reserved for lesions which are inaccessible to surgery and for disseminated visceral involvement. The latter may run an unpredictable course for which treatment is not always effective [21] .
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Conclusion
Langerhans cell histiocytosis is a rare disease, There 
